Lung transplantation for pleuroparenchymal fibroelastosis after chemotherapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 25441830.
- Also identified by DOI 10.1016/j.athoracsur.2014.07.045.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report the youngest patient ever reported in the literature to exhibit pleuroparenchymal fibroelastosis (PPFE) as a late-onset pulmonary toxicity after treatment with anticancer chemotherapy. The patient was diagnosed with mature B-cell leukemia at age 14. He was successfully treated with intensive chemotherapy; however, 7 years later, he experienced recurrent pneumothoraces. He was clinically diagnosed with upper lobe pulmonary fibrosis. At age 28, he underwent single left lung transplantation. Histologic examination of the resected lung revealed PPFE in the upper lobe and constrictive bronchiolitis obliterans in the lower lobe, which implied a close relationship between PPFE and constrictive bronchiolitis obliterans.
Medical subject headings
- Antineoplastic Agents
- Bronchiolitis Obliterans
- Leukemia, B-Cell
- Lung Transplantation
- Pleural Diseases